Holdings/Fund Details
Top Ten Holdings
as of 03/31/2020 subject to change
| Novartis AG | 4.01% |
| Roche Holding AG | 3.69% |
| Ascendas Real Estate Investment Trust | 3.58% |
| Iberdrola SA | 3.50% |
| Sanofi | 3.45% |
| Nestle SA | 3.39% |
| Sonic Healthcare Ltd. | 3.35% |
| GlaxoSmithKline PLC | 3.19% |
| Zurich Insurance Group AG | 3.16% |
| Unilever NV | 3.13% |
Portfolio Characteristics as of 03/31/2020
Retail
| Average P/E |
12.5 |
| 30 Day SEC Yield1 |
3.35% |
| 30-Day Unsubsidized SEC Yield1 |
3.01% |
| 12 Month Trailing Distributed Yield2 |
4.39% |
| Weighted Average Market Cap. |
84.1 |
| Median Market Cap. |
36.5 |
| Long-Term EPS Growth |
9.7 |
Top 5 Countries as of 03/31/2020
| Switzerland |
17.0% |
| United Kingdom |
14.3% |
| France |
9.4% |
| Germany |
8.7% |
| Japan |
7.9% |
Sector Breakdownas of 03/31/2020
Portfolio Allocation
as of 03/31/2020
130-day SEC yield is a compounded and annualized figure calculated according to a formula set by the SEC. The formula requires use of a specific methodology for calculating dividends and interest earned, and expenses accrued, during the period, and reflects the maximum offering price per fund share. The standardized computation is designed to facilitate yield comparisons among different funds. In the absence of temporary expense waivers or reimbursements by the Adviser, the 30-day yield would have been 3.01%.
212 Month Trailing Distributed Yield represents all distributions for over the past 12 months, divided by the net asset value at the time of the report plus any capital gains distributed over the past year. Capital gains are added back to estimate what the fund's ending price would have been had those gains not been distributed. While the Fund endeavors to pay quarterly distributions, dividends are not guaranteed and a company's future ability to pay dividends may be limited and cease at any time.
